COMBAT Medical’s patented hyperthermic technologies are helping to transform cancer treatments globally. Used in hospitals in over 40 countries worldwide to treat bladder and peritoneal cancers. Combat is committed to investing in research and development, clinical trials and evidence-based studies to prove the efficacy of its technology and create a solid foundation for use. Over 1000 patients are currently in clinical trials and in excess of 2000 treatments are given to patients each month. Combat works closely with healthcare professionals worldwide and partners with a global network of distributors to ensure that its devices are available to bladder and peritoneal cancer patients in as many countries as possible.